Analyst Expectations For Sarepta Therapeutics's Future
Analyst Expectations For Sarepta Therapeutics's Future
分析师对sarepta therapeutics未来的预期
The standing of...14 analysts have expressed a variety of opinions on Sarepta Therapeutics (NASDAQ:SRPT) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的一个季度中，有14位分析师对Sarepta Therapeutics（纳斯达克股票代码：SRPT）表达了各种看法，从看涨到看跌，提出了各种各样的观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $168.79, a high estimate of $205.00, and a low estimate of $80.00. Experiencing a 5.56% decline, the current average is now lower than the previous average price target of $178.73.
分析师为Sarepta Therapeutics设定了12个月的目标股价，显示平均目标股价为168.79美元，最高估计为205.00美元，低估值为80.00美元。目前的平均价格下降了5.56％，现在低于之前的平均目标股价178.73美元。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The standing of...
通过对...
登录免费看全文
登录/注册
资讯热榜
更新时间